Subgroup comparisons—adjusted prevalence ratios of individual prevention strategies based on selected variables
| Sl no | Comparison | Smoking cessation PR (95% CI), p value | BMI target PR (95% CI), p value | BP target PR (95% CI), p value | LDL target PR (95% CI), p value | PA target PR (95% CI), p value | HbA1c target PR (95% CI), p value |
| 1 | Age | ||||||
| 60–80 years vs 30–<60 years | 0.98 (0.94 to 1.03), 0.39 | 0.93 (0.85 to 1.02), 0.13 | 1.12 (1.03 to 1.21), 0.005 | 0.90 (0.82 to 1.00), 0.05 | 1.3 6(1.18 to 1.57), <0.0001 | 1.01 (0.96 to 1.06), 0.61 | |
| 2 | Sex | ||||||
| Female vs male | 1.06 (1.02 to 1.10), 0.0021 | 0.93 (0.83 to 1.02), 0.15 | 0.87 (0.78 to 0.97), 0.01 | 0.95 (0.84 to 1.05), 0.32 | 0.49 (0.39 to 0.62), <0.0001 | 1.04 (0.99 to 1.09), 0.08 | |
| 3 | SES | ||||||
| High vs low | 0.94 (0.77 to 1.15), 0.55 | 0.85 (0.66 to 1.10), 0.23 | 1.25 (1.05 to 1.47), 0.009 | 0.79 (0.60 to 1.04), 0.10 | 1.35 (0.96 to 1.91), 0.08 | 0.81 (0.67 to 0.97), 0.03 | |
| Medium vs low | 0.99 (0.94 to 1.03), 0.66 | 0.89 (0.82 to 0.97), 0.01 | 1.05 (0.95 to 1.14), 0.35 | 0.78 (0.71 to 0.86), <0.0001 | 1.38 (1.15 to 1.66), 0.0004 | 0.93 (0.89 to 0.97), 0.03 | |
| 4 | Place of domicile | ||||||
| Urban vs rural | 1.02 (0.97 to 1.06), 0.41 | 1.03 (0.95 to 1.13), 0.39 | 1.02 (0.94 to 1.11), 0.52 | 0.92 (0.83 to 1.01), 0.11 | 0.88 (0.76 to 1.03), 0.10 | 1.00 (0.96 to 1.05), 0.87 | |
| 5 | Insurance | ||||||
| Yes vs no | 1.04 (0.95 to 1.06), 0.86 | 0.95 (0.86 to 1.03), 0.25 | 0.92 (0.84 to 1.00), 0.06 | 1.22 (1.11 to 1.34), <0.0001 | 1.17 (1.01 to 1.36), 0.02 | 1.05 (1.00 to 1.11), 0.02 | |
| 6 | Treatment taken | ||||||
| CABG vs MT | 1.03 (0.96 to 1.11), 0.39 | 1.08 (0.95 to 1.24), 0.08 | 1.11 (0.97 to 1.27), 0.122 | 0.86 (0.72 to 1.02), 0.08 | 1.28 (1.01 to 1.64), 0.03 | 0.94 (0.86 to 1.02), 0.15 | |
| PTCA vs MT | 1.00 (0.99 to 1.08), 0.05 | 1.03 (0.93 to 1.14), 0.49 | 1.07 (0.97 to 1.19), 0.16 | 0.87 (0.78 to 0.97), 0.0097 | 1.23 (1.02 to 1.49), 0.02 | 0.99 (0.94 to 1.04), 0.79 |
BMI, body mass index; CABG, coronary arteries bypass graft; HbA1c, glycosylated haemoglobin; LDL, low-density lipoprotein; MT, medical therapy; PA, physical activity; PTCA, percutaneous transluminal coronary angioplasty; SES, socioeconomic status.